CoChat

Immune oncology, immune responsiveness and the theory of everything

Open access
Turan, Tolga, Kannan, Deepti, Patel, Maulik, Matthew Barnes, J., Tanlimco, Sonia G., Lu, Rongze, Halliwill, Kyle, Kongpachith, Sarah, Kline, Douglas E., Hendrickx, Wouter, Cesano, Alessandra, Butterfield, Lisa H., Kaufman, Howard L., Hudson, Thomas J., Bedognetti, Davide, Marincola, Francesco, Samayoa, Josue · 2018 · Journal for ImmunoTherapy of Cancer
Cited by 75

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Abstract

Anti-cancer immunotherapy is encountering its own checkpoint. Responses are dramatic and long lasting but occur in a subset of tumors and are largely dependent upon the pre-existing immune contexture of individual cancers. Available data suggest that three landscapes best define the cancer microenvironment: immune-active, immune-deserted and immune-excluded. This trichotomy is observable across most solid tumors (although the frequency of each landscape varies depending on tumor tissue of origin) and is associated with cancer prognosis and response to checkpoint inhibitor therapy (CIT). Various gene signatures (e.g. Immunological Constant of Rejection - ICR and Tumor Inflammation Signature - TIS) that delineate these landscapes have been described by different groups. In an effort to explain the mechanisms of cancer immune responsiveness or resistance to CIT, several models have been proposed that are loosely associated with the three landscapes. Here, we propose a strategy to integrate compelling data from various paradigms into a "Theory of Everything". Founded upon this unified theory, we also propose the creation of a task force led by the Society for Immunotherapy of Cancer (SITC) aimed at systematically addressing salient questions relevant to cancer immune responsiveness and immune evasion. This multidisciplinary effort will encompass aspects of genetics, tumor cell biology, and immunology that are pertinent to the understanding of this multifaceted problem.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s40425-018-0355-5

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 75

Metadata

Authors
Turan, T., Kannan, D., Patel, M., Matthew Barnes, J., Tanlimco, S. G., Lu, R., Halliwill, K., Kongpachith, S., Kline, D. E., Hendrickx, W., Cesano, A., Butterfield, L. H., Kaufman, H. L., Hudson, T. J., Bedognetti, D., Marincola, F., & Samayoa, J.
Venue
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Published
2018-06-05
Volume
6
Issue
1
Pages
50-50
ISSN
2051-1426 (ISSN-L)
OpenAlex
W2806916167
Cited by
75
References
24
FWCI
4.04
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune oncology, immune responsiveness and the theory of everything. https://app.cochat.ai/papers/10.1186/s40425-018-0355-5
The paper
Turan, T., Kannan, D., Patel, M., Matthew Barnes, J., Tanlimco, S. G., Lu, R., Halliwill, K., Kongpachith, S., Kline, D. E., Hendrickx, W., Cesano, A., Butterfield, L. H., Kaufman, H. L., Hudson, T. J., Bedognetti, D., Marincola, F., & Samayoa, J. (2018). Immune oncology, immune responsiveness and the theory of everything. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1186/s40425-018-0355-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.